Related Experiment Video
Updated: Mar 5, 2026
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model
L Stankevicins1,2, A Barat2, P Dessen3
1Departamento de Genética, Universidade do Estado do Rio de Janeiro, Instituto de Biologia Roberto Alcantara Gomes, Rio de Janeiro, Brazil.
Abstract:
MicroRNA is a class of noncoding RNAs able to base pair with complementary messenger RNA sequences, inhibiting their expression. These regulatory molecules play important roles in key cellular processes including cell proliferation, differentiation and response to DNA damage; changes in miRNA expression are a common feature of human cancers. To gain insights into the mechanisms involved in breast cancer progression we conducted a microRNA global expression analysis on a 21T series of cell lines obtained from the same patient during different stages of breast cancer progression. These stages are represented by cell lines derived from normal epithelial (H16N2), atypical ductal hyperplasia (21PT), primary in situ ductal carcinoma (21NT) and pleural effusion of a lung metastasis (21MT-1 and 21MT-2). In a global microRNA expression analysis, miR-205-5p was the only miRNA to display an important downregulation in the metastatic cell lines (21MT-1; 21MT-2) when compared to the non-invasive cells (21PT and 21NT). The lower amounts of miR-205-5p found also correlated with high histological grades biopsies and with higher invasion rates in a Boyden chamber assay. This work pinpoints miR-205-5p as a potential player in breast tumor invasiveness.
Insights
MicroRNA (miRNA) research reveals miR-205-5p is significantly downregulated in metastatic breast cancer cell lines. This finding suggests miR-205-5p may play a crucial role in breast tumor invasiveness and progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are regulatory noncoding RNAs impacting cellular processes.
- Altered miRNA expression is characteristic of human cancers, including breast cancer.
- Understanding miRNA roles is key to deciphering breast cancer progression mechanisms.
Purpose of the Study:
- To investigate global microRNA expression changes during breast cancer progression.
- To identify specific miRNAs associated with metastatic potential in breast cancer cell lines.
Main Methods:
- Global microRNA expression analysis was performed on a series of breast cancer cell lines representing different stages of progression.
- Cell lines included normal epithelial, atypical hyperplasia, in situ carcinoma, and metastatic carcinoma.
- miR-205-5p expression levels were compared between non-invasive and metastatic cell lines.
Main Results:
- miR-205-5p was the sole miRNA significantly downregulated in metastatic breast cancer cell lines (21MT-1, 21MT-2) compared to non-invasive ones (21PT, 21NT).
- Lower miR-205-5p levels correlated with higher histological grades and increased invasion rates in vitro.
- This suggests a link between reduced miR-205-5p and enhanced tumor invasiveness.
Conclusions:
- miR-205-5p is identified as a potential key regulator in breast tumor invasiveness.
- Downregulation of miR-205-5p may contribute to the progression and metastatic potential of breast cancer.
- Further research into miR-205-5p's function could offer new therapeutic targets for breast cancer.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...